[SYRE] QoQ Quarter Result on 30-Jun-2020 [#Q2]

Stock
[SYRE] Spyre Therapeutics, Inc.
Announcement Date
30-Jun-2020
Financial Year
2020
Quarter
30-Jun-2020 [#Q2]
Profit Trend
QoQ- -14.36%
YoY- -18.86%
Quarter Report
SYRE's Result
SYRE's Financial Summary
View:
Show?
Quarter Result
31/03/21 31/12/20 30/09/20 30/06/20 31/03/20 31/12/19 30/09/19 CAGR
Revenue 0 0 0 0 0 0 0 -
PBT -18,218 -22,714 -18,033 -21,418 -18,728 -21,495 -21,573 -10.64%
Tax 0 0 0 0 0 0 0 -
NP -18,218 -22,714 -18,033 -21,418 -18,728 -21,495 -21,573 -10.64%
Tax Rate - - - - - - - -
Total Cost 18,218 22,714 18,033 21,418 18,728 21,495 21,573 -10.64%
Ratio Analysis
31/03/21 31/12/20 30/09/20 30/06/20 31/03/20 31/12/19 30/09/19 CAGR
NP Margin 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -
Per Share
31/03/21 31/12/20 30/09/20 30/06/20 31/03/20 31/12/19 30/09/19 CAGR
EPS -6.94 0.00 -7.24 -10.11 -14.15 0.00 -16.40 -43.60%
EPS Diluted -6.94 0.00 -7.24 -10.11 -14.15 0.00 -16.40 -43.60%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.